Clark Capital Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$407K Sell
9,532
-108,832
-92% -$5.91M ﹤0.01% 425
2026
Q1
$7.43M Buy
118,364
+40,633
+52% +$3.25M 0.05% 201
2025
Q4
$7.41M Buy
77,731
+68,300
+724% +$6.7M 0.05% 190
2025
Q3
$921K Sell
9,431
-1,703
-15% -$176K 0.01% 298
2025
Q2
$1.2M Sell
11,134
-199
-2% -$20.1K 0.01% 288
2025
Q1
$1.14M Buy
11,333
+6,694
+144% +$674K 0.01% 287
2024
Q4
$414K Buy
4,639
+404
+10% +$35.6K ﹤0.01% 345
2024
Q3
$355K Buy
4,235
+80
+2% +$6.31K ﹤0.01% 352
2024
Q2
$320K Buy
4,155
+52
+1% +$3.81K ﹤0.01% 346
2024
Q1
$281K Buy
+4,103
New +$264K ﹤0.01% 358
2020
Q1
Sell
-5,253
Closed -$238K 283
2019
Q4
$238K Sell
5,253
-171
-3% -$7.16K 0.01% 298
2019
Q3
$221K Buy
+5,424
New +$230K 0.01% 290
2014
Q1
Sell
-13,082
Closed -$157K 340
2013
Q4
$157K Sell
13,082
-613
-4% -$7.24K 0.01% 328
2013
Q3
$161K Sell
13,695
-1,065
-7% -$11.5K 0.01% 328
2013
Q2
$137K Buy
+14,760
New +$125K 0.01% 321

Other funds holding BSX

Clark Capital Management Group's BSX Position: Q2 2026 in Review

Clark Capital Management Group reduced its Boston Scientific (BSX) stake by 92% in Q2 2026, selling an estimated $5.91M and leaving 9,532 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Clark Capital Management Group first reported a position in BSX in Q2 2013 and has held it in 15 quarters since. The position peaked at $7.43M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clark Capital Management Group held 9,532 shares of Boston Scientific worth $407K as of Q2 2026.
  • Clark Capital Management Group sold 108,832 Boston Scientific shares in Q2 2026, an estimated $5.91M.
  • Boston Scientific made up ﹤0.01% of Clark Capital Management Group's portfolio in Q2 2026, its #425 holding.
  • Clark Capital Management Group first reported a position in Boston Scientific in Q2 2013 and has held it in 15 quarters since.
  • Clark Capital Management Group's Boston Scientific position peaked at $7.43M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.